At the headquarters of the Ministry of Health (Minsa), the presentation of the care protocol for outpatients and the management of Covid-19 medications was carried out, aimed at health regions and directors of public and private hospitals.
Dr. Tatiana Carles presented the protocol that seeks to reduce the duration of symptoms, their intensity, the progression of the disease and the need for hospitalization.
“With the medications that we have, both intravenously, such as Remdesivir, and orally, Paxlovid and Molnupiravir, it is necessary to establish indications regarding age, contraindications, and risk groups,” said Carles.
For his part, the advisor to the Minsa, Alessandro Ganci, said that the doctors will determine what medication they will give to Covid-19 patients, in the first five days of testing positive.
“Panama is fortunate to be the first country in Central America to have these drugs and the first country in Latin America to have Paxlovid and the second country with Molnupiravir, which together with Remdesivir, can treat the earliest stages of COVID-19 and prevent patients from reaching hospitalization or requiring more aggressive treatments,” Ganci said.
